ShareMyTrial
Sign In
Insomnia
Published Research

Magnesium Bisglycinate for Sleep Quality in Adults

155 participants

Symptoms Studied

Difficulty falling asleep, poor sleep quality, non-restorative sleep, and daytime fatigue. Insomnia symptoms without underlying medical causes.

Research Hypothesis

Magnesium acts as a natural GABA agonist and NMDA antagonist, promoting relaxation. Glycine component may have additional calming effects on the nervous system.

Intervention Tested

Magnesium Bisglycinate (Glycinate)

250mg elemental magnesium daily (as magnesium bisglycinate/glycinate), taken in the evening

Duration: 4-8 weeks

Study Results

Before Treatment

Healthy adults with self-reported poor sleep quality and insomnia symptoms as measured by ISI (Insomnia Severity Index).

After Treatment

Magnesium bisglycinate group showed significantly greater reduction in ISI scores compared to placebo (-3.9 vs -2.3, p=0.049). Sleep onset latency reduced by 17 minutes vs placebo in meta-analysis.

Timeline to Improvement

Improvements observed by week 4 of supplementation

Side Effects

Well-tolerated. Bisglycinate form has less laxative effect than other forms. Occasional mild GI symptoms.

Source

Conclusion

Magnesium bisglycinate supplementation produces modest but significant improvements in sleep quality and insomnia symptoms in adults reporting poor sleep.

Comments (0)

Did this work for you?

Share your experience

Sign in to vote

Try It Yourself

Create your own trial based on this study and share your results.

Replicate This Trial

Similar Trials

More trials for Insomnia coming soon.

Browse all Insomnia trials